291 related articles for article (PubMed ID: 33006656)
21. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S
Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
[TBL] [Abstract][Full Text] [Related]
22.
Zhong H; Huang D; Wu J; Chen X; Chen Y; Huang C
BMC Med Imaging; 2023 Jun; 23(1):87. PubMed ID: 37370013
[TBL] [Abstract][Full Text] [Related]
23. Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma.
Nanni C; Zamagni E
PET Clin; 2019 Jul; 14(3):383-389. PubMed ID: 31084777
[TBL] [Abstract][Full Text] [Related]
24. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658
[TBL] [Abstract][Full Text] [Related]
25. Radiomic analysis for predicting prognosis of colorectal cancer from preoperative
Lv L; Xin B; Hao Y; Yang Z; Xu J; Wang L; Wang X; Song S; Guo X
J Transl Med; 2022 Feb; 20(1):66. PubMed ID: 35109864
[TBL] [Abstract][Full Text] [Related]
26. The added diagnostic value of 18 F-FDG PET/CT radiomic analysis in multiple myeloma patients with negative visual analysis.
An S; Huang G; Yu X; Liu J; Chen Y
Nucl Med Commun; 2024 Mar; 45(3):244-252. PubMed ID: 38165165
[TBL] [Abstract][Full Text] [Related]
27. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
[TBL] [Abstract][Full Text] [Related]
28. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
[TBL] [Abstract][Full Text] [Related]
29. Role of
Cavo M; Terpos E; Nanni C; Moreau P; Lentzsch S; Zweegman S; Hillengass J; Engelhardt M; Usmani SZ; Vesole DH; San-Miguel J; Kumar SK; Richardson PG; Mikhael JR; da Costa FL; Dimopoulos MA; Zingaretti C; Abildgaard N; Goldschmidt H; Orlowski RZ; Chng WJ; Einsele H; Lonial S; Barlogie B; Anderson KC; Rajkumar SV; Durie BGM; Zamagni E
Lancet Oncol; 2017 Apr; 18(4):e206-e217. PubMed ID: 28368259
[TBL] [Abstract][Full Text] [Related]
30. A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy.
Paschali A; Panagiotidis E; Triantafyllou T; Palaska V; Tsirou K; Verrou E; Υiannaki E; Markala D; Papanikolaou A; Pouli A; Konstantinidou P; Chatzipavlidou V; Terpos E; Katodritou E
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1487-1497. PubMed ID: 33099659
[TBL] [Abstract][Full Text] [Related]
31. Utility and prognostic value of
Aljama MA; Sidiqi MH; Buadi FK; Lacy MQ; Gertz MA; Dispenzieri A; Dingli D; Muchtar E; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Warsame RM; Kourelis T; Hwa YL; Kapoor P; Kyle RA; Leung N; Go RS; Rajkumar SV; Kumar SK
Am J Hematol; 2018 Dec; 93(12):1518-1523. PubMed ID: 30194770
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
Zhang Y; Zhou J; Wang L; Li JY; Ding CY
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):885-890. PubMed ID: 33113633
[No Abstract] [Full Text] [Related]
33. Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On
Cho HJ; Baek DW; Kim JH; Lee J; Chung YK; Jung SH; Song GY; Ahn SY; Ahn JS; Yang DH; Lee JJ; Kim HJ; Hong CM; Jeong SY; Min JJ; Sohn SK; Moon JH
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):113-120. PubMed ID: 34598908
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of
Li Q; Hu L; Charwudzi A; Zhu W; Meng Y; Zhai Z
Clin Exp Med; 2023 Feb; 23(1):31-43. PubMed ID: 35000022
[TBL] [Abstract][Full Text] [Related]
35. A prognostication system based on clinical parameters and [
Li J; Zhang X; Qin C; Sun X; Xu X; Cao G; Gai Y; Sun C; Hu Y; Lan X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1665-1670. PubMed ID: 36576511
[TBL] [Abstract][Full Text] [Related]
36. Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma.
Jamet B; Zamagni E; Nanni C; Bailly C; Carlier T; Touzeau C; Michaud AV; Moreau P; Bodet-Milin C; Kraeber-Bodere F
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751375
[TBL] [Abstract][Full Text] [Related]
37. 11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma.
Chen M; Zhu W; Du J; Yang C; Han B; Zhou D; Huo L; Zhuang J
Sci Rep; 2021 Nov; 11(1):22188. PubMed ID: 34773054
[TBL] [Abstract][Full Text] [Related]
38. Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma.
Haznedar R; Akı SZ; Akdemir OU; Ozkurt ZN; Ceneli O; Yağcı M; Sucak GT; Unlü M
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1046-53. PubMed ID: 21287167
[TBL] [Abstract][Full Text] [Related]
39. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
40. Molecular Signature of
Alberge JB; Kraeber-Bodéré F; Jamet B; Touzeau C; Caillon H; Wuilleme S; Béné MC; Kampfenkel T; Sonneveld P; van Duin M; Avet-Loiseau H; Corre J; Magrangeas F; Carlier T; Bodet-Milin C; Chérel M; Moreau P; Minvielle S; Bailly C
J Nucl Med; 2022 Jul; 63(7):1008-1013. PubMed ID: 35086897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
